Rocket Pharmaceuticals Inc (RCKT)
21.86
+0.31
(+1.44%)
USD |
NASDAQ |
May 01, 11:08
Rocket Pharmaceuticals Shareholders Equity (Quarterly): 492.57M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 492.57M |
| September 30, 2023 | 541.09M |
| June 30, 2023 | 402.97M |
| March 31, 2023 | 458.88M |
| December 31, 2022 | 489.69M |
| September 30, 2022 | 367.31M |
| June 30, 2022 | 387.70M |
| March 31, 2022 | 417.62M |
| December 31, 2021 | 454.72M |
| September 30, 2021 | 485.66M |
| June 30, 2021 | 489.44M |
| March 31, 2021 | 480.00M |
| December 31, 2020 | 503.52M |
| September 30, 2020 | 241.84M |
| June 30, 2020 | 266.52M |
| March 31, 2020 | 286.05M |
| December 31, 2019 | 307.30M |
| September 30, 2019 | 231.92M |
| June 30, 2019 | 248.50M |
| March 31, 2019 | 177.08M |
| Date | Value |
|---|---|
| December 31, 2018 | 194.04M |
| September 30, 2018 | 143.62M |
| June 30, 2018 | 157.08M |
| March 31, 2018 | 170.15M |
| December 31, 2017 | 47.76M |
| September 30, 2017 | 51.08M |
| June 30, 2017 | 57.53M |
| March 31, 2017 | 63.26M |
| December 31, 2016 | 73.17M |
| September 30, 2016 | 85.05M |
| June 30, 2016 | 95.44M |
| March 31, 2016 | 99.24M |
| December 31, 2015 | 108.81M |
| September 30, 2015 | 116.48M |
| June 30, 2015 | 31.72M |
| March 31, 2015 | 33.95M |
| December 31, 2014 | -51.56M |
| September 30, 2014 | -0.316M |
| December 31, 2013 | -38.90M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
231.92M
Minimum
Sep 2019
541.09M
Maximum
Sep 2023
397.54M
Average
417.62M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| ADMA Biologics Inc | 135.21M |
| Geron Corp | 247.95M |
| Madrigal Pharmaceuticals Inc | 405.33M |
| Ligand Pharmaceuticals Inc | 700.91M |
| Puma Biotechnology Inc | 53.44M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 566.34M |
| Total Liabilities (Quarterly) | 73.77M |